Literature DB >> 23722635

Don't middle your MIDs: regression to the mean shrinks estimates of minimally important differences.

Peter M Fayers1, Ron D Hays.   

Abstract

Minimal important differences (MIDs) for patient-reported outcomes (PROs) are often estimated by selecting a clinical variable to serve as an anchor. Then, differences in the clinical anchor regarded as clinically meaningful or important can be used to estimate the corresponding value of the PRO. Although these MID values are sometimes estimated by regression techniques, we show that this is a biased procedure and should not be used; alternative methods are proposed.

Entities:  

Mesh:

Year:  2013        PMID: 23722635      PMCID: PMC3961825          DOI: 10.1007/s11136-013-0443-4

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  12 in total

1.  Hi! How are you? Response shift, implicit theories and differing epistemologies.

Authors:  Geoffrey Norman
Journal:  Qual Life Res       Date:  2003-05       Impact factor: 4.147

2.  Approaches and recommendations for estimating minimally important differences for health-related quality of life measures.

Authors:  Ron D Hays; Sepideh S Farivar; Honghu Liu
Journal:  COPD       Date:  2005-03       Impact factor: 2.409

3.  Linking scores from multiple health outcome instruments.

Authors:  Neil J Dorans
Journal:  Qual Life Res       Date:  2007-02-08       Impact factor: 4.147

Review 4.  Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.

Authors:  Dennis Revicki; Ron D Hays; David Cella; Jeff Sloan
Journal:  J Clin Epidemiol       Date:  2007-08-03       Impact factor: 6.437

5.  Should linking replace regression when mapping from profile-based measures to preference-based measures?

Authors:  Peter M Fayers; Ron D Hays
Journal:  Value Health       Date:  2014-03       Impact factor: 5.725

6.  Measurement of health status. Ascertaining the minimal clinically important difference.

Authors:  R Jaeschke; J Singer; G H Guyatt
Journal:  Control Clin Trials       Date:  1989-12

Review 7.  Interpreting patient-reported outcome results: US FDA guidance and emerging methods.

Authors:  Lori D McLeod; Cheryl D Coon; Susan A Martin; Sheri E Fehnel; Ron D Hays
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2011-04       Impact factor: 2.217

8.  Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma.

Authors:  Ann K Kvam; Finn Wisløff; Peter M Fayers
Journal:  Health Qual Life Outcomes       Date:  2010-08-03       Impact factor: 3.186

9.  Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials.

Authors:  Ivan J Suñer; Gregg T Kokame; Elaine Yu; James Ward; Chantal Dolan; Neil M Bressler
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-28       Impact factor: 4.799

10.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.

Authors: 
Journal:  Health Qual Life Outcomes       Date:  2006-10-11       Impact factor: 3.186

View more
  31 in total

Review 1.  Best (but oft-forgotten) practices: expressing and interpreting associations and effect sizes in clinical outcome assessments.

Authors:  Lori D McLeod; Joseph C Cappelleri; Ron D Hays
Journal:  Am J Clin Nutr       Date:  2016-02-10       Impact factor: 7.045

Review 2.  Selective serotonin reuptake inhibitors for fibromyalgia syndrome.

Authors:  Brian Walitt; Gerard Urrútia; María Betina Nishishinya; Sarah E Cantrell; Winfried Häuser
Journal:  Cochrane Database Syst Rev       Date:  2015-06-05

3.  Estimating the minimum important change in the 15D scores.

Authors:  Soili Alanne; Risto P Roine; Pirjo Räsänen; Tarja Vainiola; Harri Sintonen
Journal:  Qual Life Res       Date:  2014-08-22       Impact factor: 4.147

Review 4.  Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults.

Authors:  Sheena Derry; Philip J Wiffen; Winfried Häuser; Martin Mücke; Thomas Rudolf Tölle; Rae F Bell; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-03-27

5.  Moving from significance to real-world meaning: methods for interpreting change in clinical outcome assessment scores.

Authors:  Cheryl D Coon; Karon F Cook
Journal:  Qual Life Res       Date:  2017-06-15       Impact factor: 4.147

6.  Adaptive behavior in autism: Minimal clinically important differences on the Vineland-II.

Authors:  C H Chatham; K I Taylor; T Charman; X Liogier D'ardhuy; E Eule; A Fedele; A Y Hardan; E Loth; L Murtagh; M Del Valle Rubido; A San Jose Caceres; J Sevigny; L Sikich; L Snyder; J E Tillmann; P E Ventola; K L Walton-Bowen; P P Wang; T Willgoss; F Bolognani
Journal:  Autism Res       Date:  2017-09-21       Impact factor: 5.216

7.  Interpretability of the PedsQL™ Gastrointestinal Symptoms Scales and Gastrointestinal Worry Scales in Pediatric Patients With Functional and Organic Gastrointestinal Diseases.

Authors:  James W Varni; Cristiane B Bendo; Robert J Shulman; Mariella M Self; Samuel Nurko; James P Franciosi; Miguel Saps; Shehzad Saeed; George M Zacur; Chelsea Vaughan Dark; John F Pohl
Journal:  J Pediatr Psychol       Date:  2015-02-13

8.  Long-term opioid use in non-cancer pain.

Authors:  Winfried Häuser; Fritjof Bock; Peter Engeser; Thomas Tölle; Anne Willweber-Strumpfe; Frank Petzke
Journal:  Dtsch Arztebl Int       Date:  2014-10-24       Impact factor: 5.594

9.  Efficacy, tolerability and safety of cannabis-based medicines for cancer pain : A systematic review with meta-analysis of randomised controlled trials.

Authors:  Winfried Häuser; Patrick Welsch; Petra Klose; Lukas Radbruch; Mary-Ann Fitzcharles
Journal:  Schmerz       Date:  2019-10       Impact factor: 1.107

10.  Patient-Reported Outcomes in Oncology Drug Labeling in the United States: A Framework for Navigating Early Challenges.

Authors:  Alan L Shields; Yanni Hao; Meaghan Krohe; Andrew Yaworsky; Iyar Mazar; Catherine Foley; Faisal Mehmed; Denise Globe
Journal:  Am Health Drug Benefits       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.